Mor Pavlovsky
Research Subjects
Mor Pavlovsky has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Eli Sprecher
Division of Dermatology Tel Aviv Sourasky Medical Center Tel Aviv Israel
2 shared publications - Liat Samuelov
Division of Dermatology Tel Aviv Sourasky Medical Center Tel Aviv Israel
2 shared publications - Lubna Gazi Khair
Division of Dermatology, Tel Aviv Sourasky University Medical Center (Ichilov) , Tel Aviv
2 shared publications - Bar Manori
Tel Aviv University 2 Faculty of Medical and Health Sciences Tel Aviv
1 shared publication - Eylon Sharoni
Division of Dermatology, Tel Aviv Sourasky University Medical Center (Ichilov) , Tel Aviv
1 shared publication - Hagit Matz
Division of Dermatology, Tel Aviv Sourasky University Medical Center (Ichilov) , Tel Aviv
1 shared publication
Latest Publications
- 12 October 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
An ADAR1 variant as a candidate modifier of cutaneous disease severity in familial psoriasis
In a consanguineous three-generation family, psoriasis of variable severity segregated with rare IFNGR1 and ADAR1 variants on a shared HLA-C*12:03 background. These findings position the ADAR1 variant as a modifier of psoriasis severity rather than an independent monogenic cause.
- 12 October 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
An ADAR1 variant as a candidate modifier of cutaneous disease severity in familial psoriasis
In a consanguineous three-generation family, psoriasis of variable severity segregated with rare IFNGR1 and ADAR1 variants on a shared HLA-C*12:03 background. These findings position the ADAR1 variant as a modifier of psoriasis severity rather than an independent monogenic cause.
- Open Access
- 20 February 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (5)
HMCN1 variants aggravate epidermolysis bullosa simplex phenotype
Epidermolysis bullosa simplex (EBS) refers to a heterogeneous group of inherited skin disorders characterized by blister formation within the basal cell layer. The disease is characterized by marked variations in phenotype severity, suggesting co-inheritance of genetic modifiers. We identified three deleterious variants in HMCN1 that co-segregated with a more severe phenotype in a group of 20 individuals with EBS caused by mutations in KRT14, encoding keratin 14 (K14). HMCN1 codes for hemicentin-1. Protein modeling, molecular dynamics simulations, and functional experiments showed that all three HMCN1 variants disrupt protein stability. Hemicentin-1 was found to be expressed in human skin above the BMZ. Using yeast-2-hybrid, co-immunoprecipitation, and proximity ligation assays, we found that hemicentin-1 binds K14. Three-dimensional skin equivalents grown from hemicentin-1–deficient cells were found to spontaneously develop subepidermal blisters, and HMCN1 downregulation was found to reduce keratin intermediate filament formation. In conclusion, hemicentin-1 binds K14 and contributes to BMZ stability, which explains the fact that deleterious HMCN1 variants co-segregate with a more severe phenotype in KRT14-associated EBS.
- 20 February 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (5)
Open AccessHMCN1 variants aggravate epidermolysis bullosa simplex phenotype
Epidermolysis bullosa simplex (EBS) refers to a heterogeneous group of inherited skin disorders characterized by blister formation within the basal cell layer. The disease is characterized by marked variations in phenotype severity, suggesting co-inheritance of genetic modifiers. We identified three deleterious variants in HMCN1 that co-segregated with a more severe phenotype in a group of 20 individuals with EBS caused by mutations in KRT14, encoding keratin 14 (K14). HMCN1 codes for hemicentin-1. Protein modeling, molecular dynamics simulations, and functional experiments showed that all three HMCN1 variants disrupt protein stability. Hemicentin-1 was found to be expressed in human skin above the BMZ. Using yeast-2-hybrid, co-immunoprecipitation, and proximity ligation assays, we found that hemicentin-1 binds K14. Three-dimensional skin equivalents grown from hemicentin-1–deficient cells were found to spontaneously develop subepidermal blisters, and HMCN1 downregulation was found to reduce keratin intermediate filament formation. In conclusion, hemicentin-1 binds K14 and contributes to BMZ stability, which explains the fact that deleterious HMCN1 variants co-segregate with a more severe phenotype in KRT14-associated EBS.